Inactive Instrument

Company Verseon Corp London S.E.

Equities

USU9221J1098

Biotechnology & Medical Research

Business Summary

Verseon Corporation is a pharmaceutical company. The Company's platform models interactions between a protein and a drug molecule with precision sufficient for designing drug candidates. The Company operates through the pharmaceutical research segment. The Company uses its drug discovery technology to develop a portfolio of programs targeting disease areas consisting of anti-coagulation, diabetic macular edema (DMA) and oncology. The Company's platform generates a range of drug-like, synthesizable compounds, which are then computationally tested against a disease-causing protein to identify the binders, the drug candidates that could potentially treat the disease. These computationally designed candidates are synthesized and sent through a series of disease specific in vitro and in vivo tests to identify the candidates for clinical testing in humans.

Managers

Managers TitleAgeSince
Founder - 01-12-31
Founder - 01-12-31
Founder - 01-12-31
Chief Tech/Sci/R&D Officer - 18-11-04
General Counsel - 19-04-30
- -
- -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chief Tech/Sci/R&D Officer - 18-11-04
Founder - 01-12-31
Founder - 01-12-31
Chairman - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 159,737,905 41,878,933 ( 26.22 %) 42,917 ( 0.0269 %) 26.22 %

Company contact information

Verseon Corp.

47071 Bayside Parkway

94538, Fremont

+510-225-9000

http://www.verseon.com
address Verseon Corp